Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)

, , , ,

In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study), the largest randomized cancer screening study ever for those cancers.

Tags:


Source: National Library of Medicine
Credit:

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.